Emily Rollins - May 8, 2023 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
Director
Signature
/s/ Daniel Rodriguez, as Attorney-in-Fact for Emily Rollins
Stock symbol
DLB
Transactions as of
May 8, 2023
Transactions value $
-$84,700
Form type
4
Date filed
5/10/2023, 04:50 PM
Previous filing
Mar 23, 2023
Next filing
May 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale -$84.7K -1K -15.29% $84.70 5.54K May 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transaction include 3,296 restricted stock units, which are subject to forfeiture until they vest.

Remarks:

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 8, 2023 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.